FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004157598> ?p ?o ?g. }

• W2004157598 endingPage "146" @default.
• W2004157598 startingPage "141" @default.
• W2004157598 abstract "Re-induction outcomes vary for children with acute lymphoblastic leukemia (ALL) and marrow relapse. We explored possible relationships among asparaginase (ASNase) activity levels, asparagine (ASN) depletion, anti-ASNase antibody titers, and response to re-induction therapy in children and adolescents with ALL and an 'early' first marrow relapse.After appropriate informed consent, we enrolled children and adolescents 1-21 years old with ALL and first marrow relapse within 12 months of completion of primary therapy. Induction therapy included intramuscular pegylated ASNase on Days 2 and 16. We assessed ASNase activity, anti-ASNase antibody titers against native and pegylated (E. coli) ASNase, and amino acid levels of asparagine (ASN) and glutamine (GLN) on Days 0, 14, and 35 of re-induction.Ninety-three patients were at least partially assessable. Among 21 patients with M1 marrow status at Day 35, the median Day 14 ASN level was <1 microM. This is significantly lower than the median Day 14 ASN level of 4 microM in the group of patients with M3 marrow at Day 35. Neither Day 0 nor Day 35 antibody titers predicted ASNase enzymatic activity level on Day 14. Surprisingly, Day 14 ASNase activity did not predict serum ASN level on Day 14. However, Day 0 and Day 35 anti-native ASNase antibody titers, and Day 0 anti-PEG ASNase antibody titers correlated positively with Day 14 serum ASN levels as one might expect from neutralizing antibody. Day 35 anti-PEG ASNase antibody titers did not.Patients with greater ASN depletion were more likely to achieve second remission in the context of six-drug therapy." @default.
• W2004157598 created "2016-06-24" @default.
• W2004157598 creator A5003133060 @default.
• W2004157598 creator A5004027712 @default.
• W2004157598 creator A5021712305 @default.
• W2004157598 creator A5024968001 @default.
• W2004157598 creator A5025288612 @default.
• W2004157598 creator A5027962644 @default.
• W2004157598 creator A5033167405 @default.
• W2004157598 creator A5045171992 @default.
• W2004157598 creator A5046710077 @default.
• W2004157598 creator A5058736479 @default.
• W2004157598 creator A5078227101 @default.
• W2004157598 creator A5081040243 @default.
• W2004157598 creator A5090441572 @default.
• W2004157598 date "2006-01-01" @default.
• W2004157598 modified "2023-09-27" @default.
• W2004157598 title "Asparagine depletion after pegylatedE. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: A Children's Oncology Group study (CCG-1941)" @default.
• W2004157598 cites W1576233656 @default.
• W2004157598 cites W1867192423 @default.
• W2004157598 cites W1938172798 @default.
• W2004157598 cites W1940732706 @default.
• W2004157598 cites W1944430150 @default.
• W2004157598 cites W1967362639 @default.
• W2004157598 cites W1970593462 @default.
• W2004157598 cites W1988207846 @default.
• W2004157598 cites W1989179393 @default.
• W2004157598 cites W2005688611 @default.
• W2004157598 cites W2013649602 @default.
• W2004157598 cites W2013851046 @default.
• W2004157598 cites W2018184592 @default.
• W2004157598 cites W2044970079 @default.
• W2004157598 cites W2053852136 @default.
• W2004157598 cites W2054379931 @default.
• W2004157598 cites W2056551976 @default.
• W2004157598 cites W2058767848 @default.
• W2004157598 cites W2068619849 @default.
• W2004157598 cites W2080828049 @default.
• W2004157598 cites W2096635048 @default.
• W2004157598 cites W2117623554 @default.
• W2004157598 cites W2123570109 @default.
• W2004157598 cites W2136735760 @default.
• W2004157598 cites W2227208022 @default.
• W2004157598 cites W4229728954 @default.
• W2004157598 cites W4249777235 @default.
• W2004157598 cites W426270985 @default.
• W2004157598 cites W75047609 @default.
• W2004157598 doi "https://doi.org/10.1002/pbc.20713" @default.
• W2004157598 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16425271" @default.
• W2004157598 hasPublicationYear "2006" @default.
• W2004157598 type Work @default.
• W2004157598 sameAs 2004157598 @default.
• W2004157598 citedByCount "50" @default.
• W2004157598 countsByYear W20041575982012 @default.
• W2004157598 countsByYear W20041575982013 @default.
• W2004157598 countsByYear W20041575982014 @default.
• W2004157598 countsByYear W20041575982015 @default.
• W2004157598 countsByYear W20041575982016 @default.
• W2004157598 countsByYear W20041575982017 @default.
• W2004157598 countsByYear W20041575982018 @default.
• W2004157598 countsByYear W20041575982019 @default.
• W2004157598 countsByYear W20041575982020 @default.
• W2004157598 countsByYear W20041575982021 @default.
• W2004157598 countsByYear W20041575982022 @default.
• W2004157598 countsByYear W20041575982023 @default.
• W2004157598 crossrefType "journal-article" @default.
• W2004157598 hasAuthorship W2004157598A5003133060 @default.
• W2004157598 hasAuthorship W2004157598A5004027712 @default.
• W2004157598 hasAuthorship W2004157598A5021712305 @default.
• W2004157598 hasAuthorship W2004157598A5024968001 @default.
• W2004157598 hasAuthorship W2004157598A5025288612 @default.
• W2004157598 hasAuthorship W2004157598A5027962644 @default.
• W2004157598 hasAuthorship W2004157598A5033167405 @default.
• W2004157598 hasAuthorship W2004157598A5045171992 @default.
• W2004157598 hasAuthorship W2004157598A5046710077 @default.
• W2004157598 hasAuthorship W2004157598A5058736479 @default.
• W2004157598 hasAuthorship W2004157598A5078227101 @default.
• W2004157598 hasAuthorship W2004157598A5081040243 @default.
• W2004157598 hasAuthorship W2004157598A5090441572 @default.
• W2004157598 hasConcept C126322002 @default.
• W2004157598 hasConcept C159654299 @default.
• W2004157598 hasConcept C181199279 @default.
• W2004157598 hasConcept C185592680 @default.
• W2004157598 hasConcept C203014093 @default.
• W2004157598 hasConcept C22889606 @default.
• W2004157598 hasConcept C2775895851 @default.
• W2004157598 hasConcept C2778461978 @default.
• W2004157598 hasConcept C2778904437 @default.
• W2004157598 hasConcept C2779349466 @default.
• W2004157598 hasConcept C2780007613 @default.
• W2004157598 hasConcept C2781107101 @default.
• W2004157598 hasConcept C2909962599 @default.
• W2004157598 hasConcept C32611913 @default.
• W2004157598 hasConcept C515207424 @default.
• W2004157598 hasConcept C55493867 @default.
• W2004157598 hasConcept C71924100 @default.
• W2004157598 hasConceptScore W2004157598C126322002 @default.
• W2004157598 hasConceptScore W2004157598C159654299 @default.

• next